List of insiders holdings for LIGAND PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Loeb Daniel S Former Director (1) Director | 2007-03-28 16:25:14 | 0 2,027,378 | 2,027,378 | Form 4 |
| KNOTT DAVID M Director | 2018-02-13 08:48:23 | 865,500 0 | 865,500 | Form 13G |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC INVESTMENT 10 LLC BVF INC LAMPERT MARK N 10% Owner | 2015-02-17 16:41:25 | 860,063 0 | 860,063 | Form 13G |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2015-02-17 16:41:25 | 860,063 0 | 860,063 | Form 13G |
| HIGGINS JOHN L Director | 2022-12-30 17:00:13 | 417,695 0 | 417,695 | Form 4 |
| DeSilva Nishan M VP, Finance & Strategy and CFO | 2015-05-14 17:39:50 | 245,399 0 | 245,399 | Form 4 |
| FOEHR MATTHEW W Former Executive Officer | 2022-11-03 21:06:18 | 162,187 0 | 162,187 | Form 4 |
| Aryeh Jason Director | 2024-06-18 21:25:56 | 83,524 56,619 | 140,143 | Form 4 |
| Davis Todd C Chief Executive Officer | 2024-08-09 17:52:17 | 123,010 0 | 123,010 | Form 4 |
| MEGLASSON MARTIN V-P, Discovery Research | 2010-05-11 14:14:11 | 102,250 0 | 102,250 | Form 4 |
| MAIER PAUL V Sr. V-P, CFO | 2006-11-22 15:58:26 | 94,326 0 | 94,326 | Form 4 |
| Korenberg Matthew E President & COO | 2024-09-24 19:41:15 | 93,608 0 | 93,608 | Form 4 |
| Reardon Andrew CLO & Secretary | 2024-09-25 20:54:39 | 93,478 0 | 93,478 | Form 4 |
| CROUCH TAYLOR Sr. V-P, Ops & Pres. Int'l | 2006-12-06 19:39:51 | 75,000 0 | 75,000 | Form 4 |
| Sharp John P VP Finance and CFO | 2014-02-14 20:18:31 | 65,634 0 | 65,634 | Form 4 |
| GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC 10% Owner | 2024-11-08 17:34:28 | 52,350 0 | 52,350 | Form 13G |
| BROADDUS WARNER R V-P, Gen. Counsel & Secy. | 2006-11-21 18:38:43 | 50,774 0 | 50,774 | Form 4 |
| ROBINSON DAVID E Pres, CEO & Chairman | 2006-03-14 16:08:47 | 50,000 0 | 50,000 | Form 4 |
| KOZARICH JOHN W Director | 2024-06-18 21:26:49 | 49,219 0 | 49,219 | Form 4 |
| Kazmi Syed VP, Bus. Dev. & Strategic Plan | 2012-02-13 14:17:11 | 43,230 0 | 43,230 | Form 4 |
| GROVES ERIC S V-P, Project Management | 2006-12-19 18:51:50 | 37,625 0 | 37,625 | Form 4 |
| Sabba Stephen L Director | 2024-06-25 19:45:06 | 35,622 0 | 35,622 | Form 4 |
| Dziewanowska Zofia E VP, Clinical Research | 2009-02-27 14:11:55 | 33,977 0 | 33,977 | Form 4 |
| Perry Jeffrey R Director | 2008-06-02 17:04:38 | 33,953 0 | 33,953 | Form 4 |
| Burakoff Steven J Director | 2010-02-19 13:00:51 | 30,000 0 | 30,000 | Form 4 |
| LAMATTINA JOHN L Director | 2024-12-02 20:05:58 | 29,515 0 | 29,515 | Form 4 |
| Patel Sunil Former Director Director | 2022-11-03 21:06:59 | 28,820 0 | 28,820 | Form 4 |
| Dembitz Terry A Vice President, Administration | 2007-03-09 19:15:12 | 24,980 0 | 24,980 | Form 3 |
| Berkman Charles S Former Executive Officer | 2022-11-03 21:06:31 | 23,825 0 | 23,825 | Form 4 |
| Espinoza Octavio Chief Financial Officer | 2024-12-06 19:55:21 | 22,751 0 | 22,751 | Form 4 |
| PETTTIT WILLIAM A Sr. V-P, HR and Administration | 2006-12-19 18:51:15 | 22,447 0 | 22,447 | Form 4 |
| LITALIEN JAMES J Sr. V-P, Reg Affairs & Comp. | 2006-03-14 16:07:53 | 20,000 0 | 20,000 | Form 4 |
| MERTES TOD V-P, Controller & Treasurer | 2006-03-14 16:08:21 | 20,000 0 | 20,000 | Form 4 |
| BLISSENBACH HENRY F Director | 2007-04-04 18:06:53 | 15,005 0 | 15,005 | Form 4 |
| NEGRO-VILAR ANDRES Exe V-P, R & D, CSO | 2006-12-14 20:39:41 | 14,940 0 | 14,940 | Form 4 |
| ALIPRANDI GIAMBATTISTA Sr.V-P, Tech, Sup & Intl Oper | 2004-06-03 15:15:53 | 12,988 0 | 12,988 | Form 4 |
| Gray Nancy Ryan Director | 2024-06-18 21:26:16 | 12,329 0 | 12,329 | Form 4 |
| Haas Jason Director | 2024-06-18 21:26:37 | 10,841 0 | 10,841 | Form 4 |
| LIGAND PHARMACEUTICALS INC Director | 2008-08-06 18:14:13 | 10,000 0 | 10,000 | Form 4 |
| GROOM JOHN Director | 2006-09-28 14:20:43 | 10,000 0 | 10,000 | Form 4 |
| PECK CARL C Director | 2006-09-28 14:21:11 | 10,000 0 | 10,000 | Form 4 |
| ROCCA MICHAEL A Director | 2006-09-28 14:21:22 | 10,000 0 | 10,000 | Form 4 |
| GREETHAM ELIZABETH M Director | 2008-06-02 15:21:10 | 10,000 0 | 10,000 | Form 4 |
| PEACOCK BRUCE Director | 2008-12-24 15:07:19 | 10,000 0 | 10,000 | Form 3 |
| Zimmermann Martine Director | 2024-06-18 21:27:25 | 8,981 0 | 8,981 | Form 4 |
| CROSS ALEXANDER D Director | 2007-01-05 13:04:22 | 3,781 0 | 3,781 | Form 4 |
| JOHNSON IRVING S Director | 2007-01-05 13:04:36 | 3,781 0 | 3,781 | Form 4 |
| Roberts Brigette Director | 2007-01-05 13:02:15 | 3,781 0 | 3,781 | Form 4 |
| Herman Melanie J Director of Accounting Director | 2016-07-05 19:56:26 | 3,611 0 | 3,611 | Form 4 |
| Boyce Sarah Former Director Director | 2022-11-03 21:06:05 | 2,892 0 | 2,892 | Form 4 |
| Cochran Jennifer R. Former Director Director | 2022-11-03 21:08:29 | 1,161 0 | 1,161 | Form 4 |
| ELAN CORP PLC 10% Owner | 2003-07-21 20:39:43 | 0 0 | 0 | Form 13D |